openPR Logo
Press release

Tuberculosis Testing Market Pegged for Robust Expansion During 2025

12-27-2017 01:51 PM CET | Health & Medicine

Press release from: Transparency Market Research

Tuberculosis Testing Market Pegged for Robust Expansion During

In order to steal a march over their competitors, keen players in the global tuberculosis testing market are banking upon strategic acquisitions. It enables them to expand their outreach into new markets and diversify their product portfolio. Besides the inorganic route, companies are also spending on research and development to come up with better products. They are also seen lapping up opportunities offered by the government for research on tuberculosis testing.

Some of the prominent players in The Global Tuberculosis Testing Market are Becton, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Hain Lifescience GmbH, Hologic Inc., Abbott Laboratories, Alere Inc., Epistem plc, Cepheid, bioMérieux SA, Akonni Biosystems Inc., LIONEX Diagnostics & Therapeutics GmbH., Danaher Corporation, Creative Diagnostics, QIAGEN, and Oxford Immunotec Ltd.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2267

As per a report by Transparency Market Research, the global tuberculosis testing market will likely expand at a tepid CAGR of 3.9% during the period between 2017 and 2025. Rising at this pace the market is projected to reach a value of US$3.18 bn by 2025.

Based on type, the global tuberculosis testing market can be segmented into chest x-ray, culture based tests, IGRA (interferon-gamma release assays), mantoux test (TST), nucleic acid testing (NAT), Xpert test, serological tests, smear microscopy, and other tests such as ADA, etc. Of them, the culture based tests held a leading share in 2016. In the years ahead too, the segment is expected to retain its dominant share vis-à-vis revenue. This is because it helps to diagnose and confirm active tuberculosis more accurately.

Geographically, the key segments of the global tuberculosis testing market are North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Among them, Asia Pacific, at present accounts for maximum share in the market in terms of revenue. It is expected to hold on to its leading revenue share in the near future too by rising at a maximum CAGR of 4.9% from 2017 to 2025.

Request to View Sample of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2267

Rising Instances of Tuberculosis Drives Market

Tuberculosis claims numerous lives annually. As per a WHO report, around 10.4 mn new tuberculosis incidents occurred in 2015. Men comprised almost 56% of that figure. Such alarming numbers have benefitted the global tuberculosis testing market.

Adds the lead analyst of the TMR report, “The global tuberculosis testing market will likely expand at an incremental pace owing to different factors such as high return on investments, first-mover advantage to the tuberculosis test kits manufacturers, growing focus on awareness programs by the governmental and non-governmental organizations, and tax credits, and fee waivers offered by the government.”

Hospital Laboratories Generate Maximum Demand

Currently, hospital laboratories generate maximum demand in the global tuberculosis testing market. The growth in the hospital laboratories can be attributed to the cost effective tests available in hospital laboratories. The physician's office laboratories segment is another key segment which is proliferating worldwide because of their cost effectiveness.

Purchase this Report @

https://www.transparencymarketresearch.com/checkout.php?rep_id=2267<ype=S

About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Tuberculosis Testing Market Pegged for Robust Expansion During 2025 here

News-ID: 877411 • Views:

More Releases from Transparency Market Research

Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Study
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Stud …
The global 𝐭𝐢𝐬𝐬𝐮𝐞 𝐛𝐚𝐧𝐤𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 reached a value of US$ 1,056.4 million in 2017 and is projected to nearly triple to US$ 2,903.3 million by 2026, with a robust Compound Annual Growth Rate (CAGR) of approximately 12.0% from 2018 to 2026. Factors such as increasing awareness about tissue donation, technological advancements, and a growing target patient population are anticipated to propel market growth during this period. Moreover, the market is expected
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
This report by Transparency Market Research, Inc. assesses the present state and future growth potential of the global 𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐜𝐥𝐨𝐬𝐮𝐫𝐞 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭. It features a comprehensive executive summary, offering insights into various segments of the market. Additionally, the report provides detailed analysis and data on product, access type, application, end user, and regional segments within the global market. Vascular closure devices is estimated to reach a value of ~US$ 1 Bn
Digital Health Market Estimated at US$ 1.1 Trillion by 2031, TMR Study
Digital Health Market Estimated at US$ 1.1 Trillion by 2031, TMR Study
In 2022, the worldwide 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐇𝐞𝐚𝐥𝐭𝐡 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 garnered a valuation of US$ 382.5 billion. Projections indicate a steady growth trajectory, with a compound annual growth rate (CAGR) of 13.1% anticipated from 2023 to 2031, ultimately culminating in a total valuation of US$ 1.1 trillion by the conclusion of 2031. Market analysts foresee a promising outlook characterized by the burgeoning prevalence of chronic diseases and the increasing adoption of smartphones and internet
Global Data Center Networking Market Set to Surge, Forecasted to Reach US$ 56.3 …
The Data Center Networking Market is poised for remarkable growth, driven by the burgeoning demand for cloud-native applications and the rapid adoption of data center virtualization and cloud computing. With an estimated value of US$20.6 billion in 2021, the market is projected to surge at a robust CAGR of 10.8% from 2022 to 2031, reaching a staggering US$56.3 billion by the end of 2031. Get Sample Copy of This Report at:

All 5 Releases


More Releases for Tuberculosis

World Tuberculosis Day - Tuberculosis, the invisible pandemic
Tuberculosis is a disease that, every year, kills as many as COVID-19 does. March 24, World Tuberculosis Day, marks the anniversary of a momentous occasion - the discovery of the bacterium which causes tuberculosis in 1882. More than a hundred years after its discovery, tuberculosis is still a global health crisis. It is the leading cause of death from a single infectious disease agent, killing close to as many people per
Ocular Tuberculosis Therapeutics Market To Expand On Account Of Rising Tuberculo …
Research Nester released a report titled “Ocular Tuberculosis Therapeutics Market: Global Demand Analysis & Opportunity Outlook 2027” which delivers detailed overview of the global ocular tuberculosis therapeutics market in terms of market segmentation by treatment, by end user and by region. Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model. Ocular tuberculosis is a type
Tuberculosis Diagnosis and Treatment Market
The Global Tuberculosis diagnosis and treatment market is relied upon to develop at a CAGR of 2.3 % amid 2017-2022. An irresistible illness caused by the bacterium Mycobacterium tuberculosis (MTB) is known as Tuberculosis (TB). Tuberculosis by and large influences the lungs yet can likewise influence different parts of the body. Inert tuberculosis is the sort of TB which don't have indications. Around 10% of inert contaminations advance to dynamic
Tuberculosis Testing Market | Analysis & Trends 2020
Key players in the Global Tuberculosis (TB) Testing Market, according to a report by Transparency Market Research, are Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Hain Lifescience GmbH, Hologic Inc. QIAGEN, Abbott Laboratories, Alere Inc., Epistem plc, Cepheid, bioMérieux SA, Akonni Biosystems Inc., and Sanofi. Among them, the top players namely, Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, and Hain Lifescience GmbH
Global Tuberculosis Testing Market Driven by Increasing Incidences of Tuberculos …
A considerable portion of the population across geographies are suffering from a wide range of infectious diseases such as influenza, tuberculosis, AIDS, and several other bacterial and viral diseases. Tuberculosis or TB is one of the leading causes of death worldwide. Currently, organizations such as the World Health Organization (WHO) and the Foundation for Innovative New Diagnostics (FIND) have contributed largely towards improving global awareness regarding TB, its diagnosis, and
Tuberculosis Testing Market to Reach US$2.6 bn by 2020 owing to Increasing Tuber …
A considerable portion of the population across geographies are suffering from a wide range of infectious diseases such as influenza, tuberculosis, AIDS, and several other bacterial and viral diseases. Tuberculosis or TB is one of the leading causes of death worldwide. Currently, organizations such as the World Health Organization (WHO) and the Foundation for Innovative New Diagnostics (FIND) have contributed largely towards improving global awareness regarding TB, its diagnosis, and